| Preparedness and response to COVID-19 in Saudi Arabia: Building on MERS experience AA Algaissi, NK Alharbi, M Hassanain, AM Hashem Journal of infection and public health 13 (6), 834-838, 2020 | 420 | 2020 |
| ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice NK Alharbi, E Padron-Regalado, CP Thompson, A Kupke, D Wells, ... Vaccine 35 (30), 3780-3788, 2017 | 181 | 2017 |
| Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley fever GM Warimwe, J Gesharisha, BV Carr, S Otieno, K Otingah, D Wright, ... Scientific reports 6 (1), 20617, 2016 | 125 | 2016 |
| Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial M Bosaeed, A Alharbi, E Mahmoud, S Alrehily, M Bahlaq, Z Gaifer, ... Clinical Microbiology and infection 28 (4), 602-608, 2022 | 102 | 2022 |
| Humoral immunogenicity and efficacy of a single dose of ChAdOx1 MERS vaccine candidate in dromedary camels NK Alharbi, I Qasim, A Almasoud, HA Aljami, MW Alenazi, A Alhafufi, ... Scientific reports 9 (1), 16292, 2019 | 101 | 2019 |
| Interferon beta-1b and lopinavir–ritonavir for Middle East respiratory syndrome YM Arabi, AY Asiri, AM Assiri, HH Balkhy, A Al Bshabshe, M Al Jeraisy, ... New England Journal of Medicine 383 (17), 1645-1656, 2020 | 88 | 2020 |
| Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals HA Alserehi, AM Alqunaibet, JA Al-Tawfiq, NK Alharbi, AN Alshukairi, ... Diagnostic microbiology and infectious disease 99 (3), 115273, 2021 | 80 | 2021 |
| A highly immunogenic, protective, and safe adenovirus-based vaccine expressing Middle East respiratory syndrome coronavirus S1-CD40L fusion protein in a transgenic human … AM Hashem, A Algaissi, AS Agrawal, SS Al-Amri, RY Alhabbab, ... The Journal of infectious diseases 220 (10), 1558-1567, 2019 | 64 | 2019 |
| Early humoral response correlates with disease severity and outcomes in COVID-19 patients AM Hashem, A Algaissi, SA Almahboub, MA Alfaleh, TS Abujamel, ... Viruses 12 (12), 1390, 2020 | 59 | 2020 |
| Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial M Bosaeed, HH Balkhy, S Almaziad, HA Aljami, H Alhatmi, H Alanazi, ... The Lancet Microbe 3 (1), e11-e20, 2022 | 44 | 2022 |
| Nationwide seroprevalence of SARS-CoV-2 in Saudi arabia NK Alharbi, S Alghnam, A Algaissi, H Albalawi, MW Alenazi, ... Journal of infection and public health 14 (7), 832-838, 2021 | 34 | 2021 |
| Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA T Orubu, NK Alharbi, T Lambe, SC Gilbert, MG Cottingham PloS one 7 (6), e40167, 2012 | 34 | 2012 |
| Early prediction of COVID-19 ventilation requirement and mortality from routinely collected baseline chest radiographs, laboratory, and clinical data with machine learning AF Aljouie, A Almazroa, Y Bokhari, M Alawad, E Mahmoud, E Alawad, ... Journal of Multidisciplinary Healthcare, 2017-2033, 2021 | 33 | 2021 |
| Transcriptomics-based characterization of the toxicity of ZnO nanoparticles against chronic myeloid leukemia cells SA Alsagaby, R Vijayakumar, M Premanathan, S Mickymaray, W Alturaiki, ... International Journal of Nanomedicine, 7901-7921, 2020 | 30 | 2020 |
| Vaccines against Middle East respiratory syndrome coronavirus for humans and camels NK Alharbi Reviews in medical virology 27 (2), e1917, 2017 | 29 | 2017 |
| Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016 AA Degnah, SS Al-Amri, AM Hassan, AS Almasoud, M Mousa, ... Journal of infection and public health 13 (5), 697-703, 2020 | 27 | 2020 |
| Poxviral promoters for improving the immunogenicity of MVA delivered vaccines NK Alharbi Human Vaccines & Immunotherapeutics 15 (1), 203-209, 2019 | 27 | 2019 |
| Viruses causing aseptic meningitis: a tertiary medical center experience with a multiplex PCR assay MA Aldriweesh, EA Shafaay, SM Alwatban, OM Alkethami, FN Aljuraisi, ... Frontiers in Neurology 11, 602267, 2020 | 25 | 2020 |
| High rate of circulating MERS-CoV in dromedary camels at slaughterhouses in Riyadh, 2019 TA Aljasim, A Almasoud, HA Aljami, MW Alenazi, SA Alsagaby, ... Viruses 12 (11), 1215, 2020 | 20 | 2020 |
| Proposed synchronous electric motor simulation with built-in permanent magnets for robotic systems H Attar, AT Abu-Jassar, V Lyashenko, A Al-qerem, S Sotnik, N Alharbi, ... SN Applied Sciences 5 (6), 160, 2023 | 19 | 2023 |
